Fig. 3.
Immunohistochemical finding of Fas-negative (A) and Faspositive (B) squamous carcinomas (×400). The Fas-negative carcinoma (A) shows complete loss of surface Fas expression compared to Fas-expressing reactive lymphocytes. The Fas-positive carcinoma (B) reveals diffuse membranous immunopositivity similar to that of adjacent lymphocytes.